Exploring Pyrimidine Pharmacophore as Thymidine Monophosphate Kinase Inhibitors for Antitubercular Activity: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|28|3211-3223

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.28, 2016-09, pp. : 3211-3223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial Thymidine Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 13, 2005-10 ,pp. : 1205-1219

Bentham Science Publishers

Access to resources Recommend Favorite

p38 Mitogen-Activated Protein Kinase Inhibitors: A Review on Pharmacophore Mapping and QSAR Studies

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-05 ,pp. : 1015-1035

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Design and Identification of Potent Leads Against Mycobacterium tuberculosis Thymidine Monophosphate Kinase

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-04 ,pp. : 694-705

Bentham Science Publishers

Access to resources Recommend Favorite

Pyrrolo[2,3]pyrimidine inhibitors of Janus kinase 3 protein tyrosine kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1087-1092

Informa Healthcare

Access to resources Recommend Favorite

3D QSAR Pharmacophore Modeling for c-Met Kinase Inhibitors

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1117-1125

Bentham Science Publishers

Access to resources Recommend Favorite